Track topics on Twitter Track topics that are important to you
LONDON (Reuters) - GlaxoSmithKline has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief Executive Emma Walmsley steps up her drive to improve productivity.
Original Article: GSK grabs Roche veteran and Calico scientist Barron as new R&D headNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...